SAMHD1 and lung carcinoma: To support the observations made in LAC patients, treatment of lung carcinoma-derived cell lines (A549, H1299) with the methyltransferase inhibitor 5-Aza-dC (decitabine) led to increased SAMHD1 mRNA and protein levels [81].